Get the Stockscreener App
3.80
2.98%
0.11
Pre-market:
3.78
-0.02
-0.53%
Evolent Health Inc stock is traded at $3.80, with a volume of 1.53M.
It is up +2.98% in the last 24 hours and down -19.83% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
See More
Previous Close:
$3.69
Open:
$3.72
24h Volume:
1.53M
Relative Volume:
0.52
Market Cap:
$429.63M
Revenue:
$1.89B
Net Income/Loss:
$-496.52M
P/E Ratio:
-0.7984
EPS:
-4.7598
Net Cash Flow:
$1.40M
1W Performance:
+1.60%
1M Performance:
-19.83%
6M Performance:
+47.29%
1Y Performance:
-55.76%
1-Day Range:
$3.65
$3.81
1-Week Range:
$3.58
$3.835
52-Week Range:
$2.095
$9.63
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, TEM, BTSG, TXG, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
3.80 | 473.72M | 1.89B | -496.52M | 1.40M | -4.7598 |
VEEV
Veeva Systems Inc
|
260.91 | 42.48B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
77.19 | 10.71B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
56.55 | 11.62B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
80.70 | 8.94B | 638.78M | -22.66M | 122.18M | -0.1744 |
HNGE
Hinge Health Inc
|
94.15 | 7.15B | 646.34M | -512.40M | 202.76M | -6.6871 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-25-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-13-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent Health stock gains on a TransPerfect expansion - AD HOC NEWS
Evolent Health expands language services deal with TransPerfect By Investing.com - Investing.com South Africa
Evolent Health expands language services deal with TransPerfect - Investing.com
TransPerfect Wins Evolent Telephonic Interpretation Deal - tradingview.com
Q2 Healthcare Technology for Providers Earnings: Evolent Health (NYSE:EVH) Impresses - Yahoo Finance
EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits
Evolent program flags low-value regimen years ahead of failed clinical trial - RamaOnHealthcare
Morgan Stanley slips under 5% in Evolent Health (NYSE: EVH) - Stock Titan
EVH6495551 Latest News and Headlines - TradingView
Evolent Health (EVH) President Daniel Mccarthy Sells 65,892 Shar - GuruFocus
Evolent Health President Daniel Joseph McCarthy sells 65,892 shares for $329,460 - Bitget
EVH6495551 Bond Yield and Price — FINRA:EVH6495551 - tradingview.com
Evolent Health (EVH) Institutional Ownership 2026 $EVH - MarketBeat
Evolent Health (NYSE: EVH) officer lines up 2026 stock sale - Stock Titan
EVH | Evolent Health, Inc Class FinancialsRevenue Breakdown - quiverquant.com
EVH6495551 Bond Profile — Key Metrics - tradingview.com
EVH Maintains Overweight Rating by JP Morgan -- Price Target Rai - GuruFocus
EVH Maintained by TD Cowen -- Price Target Raised to $6.00 - GuruFocus
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $6 - Moomoo
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo
1 Healthcare Stock Worth Your Attention and 2 We Brush Off - Yahoo Finance UK
5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call - Yahoo Finance
Evolent Health (NYSE:EVH) Shares Up 10%What's Next? - marketbeat.com
Evolent Health (EVH) Q2 2026 Earnings Call Transcript - The Globe and Mail
Evolent Health rated Buy despite heavy debt and losses, betting on strong growth by 2027. - Pluang
Evolent Health Q2 Earnings Review: Debt Is Distressing, But Business Is Booming (EVH) - Seeking Alpha
Truist Financial Sticks to Their Hold Rating for Evolent Health (EVH) - The Globe and Mail
Dimensional Fund Advisors LP Has $4.08 Million Stock Position in Evolent Health, Inc $EVH - marketbeat.com
EVH Maintained by Truist Securities -- Price Target Lowered to $6.00 - GuruFocus
Truist Financial Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - marketbeat.com
Truist Financial Maintains Evolent Health(EVH.US) With Hold Rating, Cuts Target Price to $6 - Moomoo
Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com Australia
Truist cuts Evolent Health stock price target on execution risks - Investing.com
Truist Securities Adjusts Price Target on Evolent Health to $6 From $7, Keeps Hold Rating - marketscreener.com
Evolent Health Shares Rise After Citigroup Upgrade - marketscreener.com
EVH Upgraded by Citigroup -- Price Target Lowered to $6.00 - GuruFocus
EVOLENT HEALTH, INC. : CITIGROUP RAISES TO BUY FROM NEUTRAL; CUTS TARGET PRICE TO $6 FROM $6.75 - Bitget
Evolent Health, Inc. (EVH) Stock Analysis: A Healthcare Tech Player with a 46% Potential Upside - DirectorsTalk Interviews
Evolent Health Price Target Cut to $6.00/Share From $7.00 by Canaccord Genuity - Moomoo
Citi Upgrades Evolent Health(EVH.US) to Buy Rating, Cuts Target Price to $6 - Moomoo
Evolent Health, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:EVH) 2026-08-10 - Seeking Alpha
EVH Looks 60.0% Undervalued on GF Value™ Despite Profitability C - GuruFocus
Canaccord cuts Evolent Health stock price target on margin outlook By Investing.com - Investing.com Nigeria
EVH Maintained by Canaccord Genuity -- Price Target Lowered to $6.00 - GuruFocus
Canaccord cuts Evolent Health stock price target on margin outlook - Investing.com
Evolent Health (NYSE:EVH) Given New $6.00 Price Target at Canaccord Genuity Group - marketbeat.com
Why (EVH) Price Action Is Critical for Tactical Trading - Stock Traders Daily
EVH Q2 2026 Deep Dive: Oncology Suite and AI Automation Drive Growth Amid Membership Headwinds - finance.yahoo.com
Evolent Health (NYSE:EVH) Announces Quarterly Earnings Results - MarketBeat
A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $5 to $6 - Moomoo
Evolent Health (NYSE:EVH) Shares Cross Below 200 Day Moving AverageTime to Sell? - MarketBeat
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):